Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. J. Wirth

Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib

Clinical Cancer Research

Cancer Research

English

Related publications

Newly Diagnosed Papillary Craniopharyngioma With BRAF V600E Mutation Treated With Single-Agent Selective BRAF Inhibitor Dabrafenib: A Case Report

English

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

Frontiers in Oncology

Cancer Research

English

The BRAF V600E Mutation Is a Predictor of the Effect of Radioiodine Therapy in Papillary Thyroid Cancer

Journal of Cancer

English

BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression

Clinical Cancer Research

Cancer Research

English

Targeted Treatment of Papillary Craniopharyngiomas Harboring BRAF V600E Mutations

Cancer Research

English

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology

Molecular Biology

English

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients With Acromegaly

Multidisciplinary

English

Granulomatosis With Polyangiitis in a Patient Treated With Dabrafenib and Trametinib for BRAF V600E Positive Lung Adenocarcinoma

Cancer Research

English

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies

Cancer Research

English